American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: SF15
Title: Surgical Oncology I
Date and Time of Session: Tuesday, October 24: 8:00 am - 9:30 am
Location: San Diego Convention Center - Room: 32AB
Description:
CME Credit Hours: 1.5
Webcast Package Available: No
Audio Package Available: No
Track:
Surgical Oncology (ONC)
Credit to Address ACS Accreditation/Verification Requirements:
Cancer
Program Participants:
Moderator
David J. Bentrem, MD, FACS
Presenter Gut Microbiome Depletion Decreases Tumor Burden in Murine Models of Cancer
Vrishketan Sethi, MD
Presenter The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution evaluation of Laparoscopic Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (HIPEC)
Jesus Esquivel, MD FACS
Discussant The American Society of Peritoneal Surface Malignancies (ASPSM) multi-institution evaluation of Laparoscopic Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy (HIPEC)
Ryan P. Merkow, MD
Presenter A Preclinical Evaluation of Minnelide in Treating Melanoma
Vrishketan Sethi, MD
Discussant A Preclinical Evaluation of Minnelide in Treating Melanoma
David J. Bentrem, MD, FACS
Presenter Disparities in Biopsychosocial Concerns when Facing a Breast Cancer Diagnosis: Results of a Distress Screening Program
Sinziana Dumitra, MD FRSCS
Discussant Disparities in Biopsychosocial Concerns when Facing a Breast Cancer Diagnosis: Results of a Distress Screening Program
Swati Kulkarni, MD, FACS
Presenter Epigenetic Modulation Enhances Immunotherapy for Hepatocellular Carcinoma
Young K. Hong, MD
Discussant Epigenetic Modulation Enhances Immunotherapy for Hepatocellular Carcinoma
Jason S. Gold, MD, FACS
Presenter Analysis of Survival After Resection of Pancreatic Adenocarcinoma: When Does Surgical Volume Matter Most?
Alexander Fisher, MD
Presenter Does the choice of chemotherapeutic agent, mitomycin C vs. oxaliplatin, matter in cytoreductive surgery and hyperthemic intraperitoneal chemotherapy?
Irada Ibrahim-Zada, MD, PhD
Discussant Does the choice of chemotherapeutic agent, mitomycin C vs. oxaliplatin, matter in cytoreductive surgery and hyperthemic intraperitoneal chemotherapy?
Ryan P. Merkow, MD
Presenter Functional Role of a Novel Epigenetic Regulator in Intrahepatic Cholangiocarcinoma (ICC)
Rebecca Marcus, MD
Discussant Functional Role of a Novel Epigenetic Regulator in Intrahepatic Cholangiocarcinoma (ICC)
Jason S. Gold, MD, FACS